Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig

Hearing Research

Volumn 144, Issue 1-2, 2000, Pages 157-167

  Cardinaal, Remco M ^a   De Groot, John C M J ^a   Huizing, Egbert H ^a   Veldman, Jan E ^a   Smoorenburg, Guido F ^a  

^a Dept Otorhinolaryngology Univ M ^*  (Netherlands)

Author keywords

Cisplatin; Guinea pig; Melanocortin; ORG 2766; Ototoxicity; Prevention

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCHLEA POTENTIAL; CONTROLLED STUDY; CORTI ORGAN; DOSE RESPONSE; DRUG INHIBITION; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; FEMALE; GUINEA PIG; HISTOLOGY; MICROSCOPY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PROTECTION; SPIRAL GANGLION; STRIA VASCULARIS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL COUNT; CISPLATIN; COCHLEA; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, INNER; ENDOLYMPHATIC HYDROPS; FEMALE; GUINEA PIGS; HAIR CELLS, OUTER; PEPTIDE FRAGMENTS;

EID: 0034104744     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(00)00061-7     Document Type: Article

References (50)

1. Bagger-Sjöbäck D., Filipek C.S., Schacht J. Characteristics and drug responses of cochlear and vestibular adenylate cyclase. Arch. Otorhinolaryngol. 228:1980;217-222.
2. Bodenner D.L., Dedon P.C., Keng P.C., Katz J.C., Borch R.F. Selective protection against cis-diamminedicloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res. 46:1986;2751-2755.
3. Campbell K.C.M., Rybak L.P., Meech R.P., Hughes L. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear. Res. 102:1996;90-98.
4. Cardinaal R.M., De Groot J.M.C.J., Huizing E.H., Veldman J.E., Smoorenburg G.F. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear. Res. 144:2000a;135-146.
5. Cardinaal R.M., De Groot J.M.C.J., Huizing E.H., Veldman J.E., Smoorenburg G.F. Cisplatin-induced ototoxicity: Morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs? Hear. Res. 144:2000b;147-156.
6. Cavaletti G., Petruccioli M.G., Tredici G., Marmiroli P., Barajon I., Fabbrica D., Di Francesco A. Effects of repeated administration of low doses of cisplatin on the rat nervous system. Int. J. Tissue React. 13:1991;151-157.
7. Chary K.K., Higby D.J., Henderson E.S., Swinerton K.D. Phase I study of high-dose cis-dichlorodiamineplatinum(II) with forced diuresis. Cancer Treat. Rep. 61:1977;367-370.
8. Ciges M., Fernández-Cervilla F., Crespo P.V., Campos A. Pantothenic acid and co-enzyme A in experimental cisplatin-induced ototoxia. Acta Otolaryngol. (Stockh.). 116:1996;263-268.
9. (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear. Res. 106:1997;9-19.
10. De Koning P., Neijt J.P., Jennekens F.G.I., Gispen W.H. ORG 2766 protects from cisplatin-induced neurotoxicity in rats. Exp. Neurol. 97:1987;746-750.
11. De Wied D., Jolles J. Neuropeptides derived from pro-opiocortin: Behavioral, physiological and neurochemical effects. Physiol. Rev. 62:1982;976-1059.
12. (4-9), ORG 2766, protects against experimental allergic neuritis. Brain. 116:1993;1059-1075.
13. Estrem S.A., Babin R.W., Ryu J.H., Moore K.C. Cisdiamminedichloro-platinum(II) ototoxicity in the guinea pig. Otolaryngol. Head Neck Surg. 89:1981;638-645.
14. Fernández-Cervilla F., Crespo P.V., Ciges M., Campos A. Early morphofunctional alterations induced by cisplatin in the cochlea. ORL. 55:1993;337-340.
15. Gabaizadeh R., Staecker H., Liu W., Kopke R., Malgrange B., Lefebvre P.P., Van de Water T.R. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol. (Stockh.). 117:1997;232-238.
16. Gandara D.R., Wiebe V.J., Perez E.A., Makuch R.W., DeGregorio M.W. Cisplatin rescue therapy: Experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate. Crit. Rev. Oncol. Hematol. 10:1990;353-365.
17. (4-9) analogue. New Engl. J. Med. 322:1990;89-94.
18. Gerritsen van der Hoop R., Hamers F.P.T., Neijt J.P., Veldman H., Gispen W.H., Jennekens F.G.I. Protection against cisplatin-induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. J. Neurol. Sci. 126:1994;109-115.
19. Gispen W.H. Therapeutic potential for melanocortins in peripheral nerve disease. Trends Pharmacol. Sci. 11:1990;221-222.
20. Hamers F.P.T., Gispen W.H., Neijt J.P. Neurotoxic side effects of cisplatin. Eur. J. Cancer. 27:1991;372-376.
21. (4-9) analog to affect cisplatin ototoxicity: An electrocochleographic study in guinea pigs. Eur. Arch. Otorhinolaryngol. 251:1994;23-29.
22. Hamers, F.P.T., Biessels, G.J., Van Dam, P.S., Gispen, W.H., 1997. Neuroprotection in diabetic and toxic neuropathies. In: Bär, P.R., Flint Beal, M. (Eds.) Neuroprotection in CNS Diseases. Marcel Dekker, New York, pp. 513-554.
23. Hasko J.A., Richardson G.P., Russell I.J., Shaw G. Transient expression of neurofilament protein during hair cell development in the mouse cochlea. Hear. Res. 45:1990;63-74.
24. Heijmen P.S., Klis S.F.L., De Groot J.C.M.J., Smoorenburg G.F. Cisplatin ototoxicity and the possibly protective effect of α-melanocyte stimulating hormone. Hear. Res. 128:1999;27-39.
25. Hoffman D. Nutritional status, glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics. Hear. Res. 31:1987;217-222.
26. Kaltenbach J.A., Church M.W., Blakley B.W., McCaslin D.L., Burgio D.L. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster. Otolaryngol. Head Neck Surg. 117:1997;493-500.
27. Koch T., Gloddek B. Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cisplatium in the inner ear of the guinea pig. Eur. Arch. Otorhinolaryngol. 248:1991;459-464.
28. Kohn S., Fradis M., Zidan J., Robinson E., Pratt H., Podoshin L., Nir I. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope. 98:1988;865-871.
29. Komune S., Asakuma S., Snow J.B. Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol. Head Neck Surg. 89:1981;275-282.
30. Konishi T., Gupta B.N., Prazma J. Ototoxicity of cis-dichlorodiammine platinum(II) in guinea pigs. Am. J. Otolaryngol. 4:1983;18-26.
31. Laurell G., Bagger-Sjöbäck D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol. (Stockh.). 111:1991;891-898.
32. Laurell G., Engström B. The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear. Res. 38:1989;27-34.
33. LoMonaco M., Milone M., Batocchi A.P., Padua L., Restuccia D., Tonali P. Cisplatin neuropathy: Clinical course and neurophysiological findings. J. Neurol. 239:1992;199-204.
34. McAlpine D., Johnstone B. The ototoxic mechanism of cisplatin. Hear. Res. 47:1990;191-203.
35. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
36. Nakai Y., Konishi K., Chang K.C., Ohashi K., Morisaki N., Minowa Y., Morimoto A. Ototoxicity of the anticancer drug cisplatin. Acta Otolaryngol. (Stockh.). 93:1982;227-232.
37. Otto W.C., Brown R.D., Gage-White L., Kupetz S., Anniko M., Penny J.E., Henley C.M. Effects of cisplatin and thiosulphate upon auditory brainstem responses of guinea pigs. Hear. Res. 35:1988;79-86.
38. Saito T., Aran J.M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL. 56:1994;315-320.
39. Saito T., Zhang Z.J., Manabe Y., Ohtsubo T., Saito H. The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs. Eur. Arch. Otorhinolaryngol. 254:1997;281-286.
40. Schacht J. Adenylate cyclase and cochlear fluid balance. Am. J. Otolaryngol. 3:1982;328-331.
41. Schweitzer V.G. Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope. 103:1993;1-52.
42. Stengs C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin-induced ototoxicity: Electrophysiological evidence of spontaneous recovery in albino guinea pigs. Hear. Res. 111:1997;103-113.
43. Stengs C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs. Hear. Res. 124:1998;99-107.
44. (4-9) analogue on cisplatin ototoxicity in relation to cisplatin dose. An electrocochleographic study in albino guinea pigs. Hear. Res. 124:1998;108-117.
45. Strand F.L., Rose K.J., Zuccarelli L.A., Kume J., Alves S.E., Antonawich F.J., Garret L.Y. Neuropeptide hormones as neurotrophic factors. Physiol. Rev. 71:1991;1017-1046.
46. Suzuki M., Kaga K. Effect of cisplatin on the negative charge barrier in strial vessels of the guinea pig. A transmission electron microscopic study using polyethyleneimine molecules. Eur. Arch. Otorhinolaryngol. 253:1996;351-355.
47. Tange R.A., Vuzevski V.D. Changes in the stria vascularis of the guinea pig due to cisplatinum. Arch. Otorhinolaryngol. 239:1984;41-47.
48. Tange R.A., Conijn E.A.J.G., Van Zeijl I.G.P.M. The cortitoxic effects of cisplatinum in the guinea pig. Arch. Otorhinolaryngol. 237:1982;17-26.
49. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., Standefer J.C. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic and toxicologic studies. Cancer. 54:1984;1269-1275.
50. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.